Literature DB >> 30632838

High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.

Benjamin W Teh1,2,3, William Chui1, Sasanka Handunnetti4, Constantine Tam4,5, Leon J Worth1,2,3, Karin A Thursky1,2,3, Monica A Slavin1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30632838     DOI： 10.1080/10428194.2018.1543884

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

Review 1.  Mucormycosis of the Central Nervous System.

Authors:  Amanda Chikley; Ronen Ben-Ami; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2019-07-08

2.  Safety and Efficacy of Intermittent High-Dose Liposomal Amphotericin B Antifungal Prophylaxis in Haemato-Oncology: An Eight-Year Single-Centre Experience and Review of the Literature.

Authors:  Jonathan Youngs; Jen Mae Low; Laura Whitney; Clare Logan; Janice Chase; Ting Yau; Matthias Klammer; Mickey Koh; Tihana Bicanic
Journal:  J Fungi (Basel)       Date:  2020-12-21

Review 3.  A Systematic Review to Assess the Relationship between Disseminated Cerebral Aspergillosis, Leukemias and Lymphomas, and Their Respective Therapeutics.

Authors:  Brianne N Sullivan; Mia A Baggett; Samantha S O'Connell; Keith M Pickett; Chad Steele
Journal:  J Fungi (Basel)       Date:  2022-07-11

4.  BTK Inhibitors Impair Platelet-Mediated Antifungal Activity.

Authors:  Vincenzo Nasillo; Ivana Lagreca; Daniela Vallerini; Patrizia Barozzi; Giovanni Riva; Monica Maccaferri; Ambra Paolini; Fabio Forghieri; Stefania Fiorcari; Rossana Maffei; Silvia Martinelli; Claudio Giacinto Atene; Ilaria Castelli; Roberto Marasca; Leonardo Potenza; Patrizia Comoli; Rossella Manfredini; Enrico Tagliafico; Tommaso Trenti; Mario Luppi
Journal:  Cells       Date:  2022-03-16       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.